Patients Stopping Slimming Jabs Gain Back Weight Far More Rapidly Compared to Dieters

A recent study reveals that individuals who discontinue new weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise programs.

Research printed in a leading medical journal points out that while overweight individuals can lose a large proportion of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month after stopping.

"Individuals using these medications should be cognizant of the risk of rapid weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.

That rate of regain implies a reversion to starting mass in about a year and a half.

Comparing Therapies

The research, which looked at dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with conventional dieting.

The team emphasize that individuals who shed pounds through lifestyle changes alone generally experience a more gradual creep back—around 0.1 kg a month—after stopping.

Understanding the Quick Rebound

Doctors believe the mode of action of the injections is key to understanding the accelerated weight return.

These medications copy a body's own chemical called GLP-1, which moderates hunger.

"Long-term administration of the hormone levels several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making binge eating a significant risk."

A Lifelong Disease?

Health authorities suggest the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.

A number of clinicians say that, given the high risk of weight regain, the therapy should be considered ongoing.

This view is echoed by drug manufacturers, who note that the findings "highlight the long-term character of excess weight," akin to managing conditions like high blood pressure.

Patient Experiences

Individuals who have stopped the medication explain a sudden return of hunger.

"It felt as if something that goes on and you're instantly extremely hungry," described a patient.

This challenge is worsened if individuals have not adopted lasting lifestyle or habit modifications during therapy.

Widespread Use

Figures suggest that millions of people in the UK have tried these injections in the last 12 months, with interest being substantial.

• Adoption is greater among women than men.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion obtain the medications through private healthcare rather than the NHS.

In conclusion, experts stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic cure and lasting health benefits likely depends on integrated lifestyle changes.